References
- SaccoRLAdamsRAlbersGGuidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guidelineStroke20063757761716432246
- YusufSZhaoFMehtaSRChrolaviciusSTognoniGFoxKKEffects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevationN Engl J Med200134549450211519503
- SabatineMSCannonCPGibsonCMAddition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevationN Engl J Med20053521179118915758000
- ChenZMJiangLXChenYPAddition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trialLancet20053661607162116271642
- SteinhublSRBergerPBMannJT3rdEarly and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trialJAMA20022882411242012435254
- DienerHCBogousslavskyJBrassLMAspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialLancet200436433133715276392
- BhattDLFoxKAHackeWClopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic eventsN Engl J Med20063541706171716531616
- ConnollySJPogueJHartRGEffect of clopidogrel added to aspirin in patients with atrial fibrillationN Engl J Med20093602066207819336502
- TakahashiYNishidaYAsaiSUtilization of health care databases for pharmacoepidemiologyEur J Clin Pharmacol20126812312921808989
- TakahashiYNishidaYNakayamaTAsaiSAdverse effect profile of trichlormethiazide: a retrospective observational studyCardiovasc Diabetol2011104521605415
- NishidaYTakahashiYNakayamaTSomaMAsaiSComparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational studyCardiovasc Diabetol2011107421827713
- NishidaYTakahashiYNakayamaTSomaMKitamuraNAsaiSEffect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical recordsCardiovasc Diabetol201093820712859
- D’AgostinoRBJrPropensity scores in cardiovascular researchCirculation20071152340234317470708
- AustinPCChiuMKoDTGoereeRTuJVPropensity score matching for estimating treatment effectsFariesDELeonACHaroJMObenchainRLAnalysis of Observational Health Care Data Using SASCary, NCSAS Press2010
- RosenbaumPRRubinDBThe central role of the propensity score in observational studies for causal effectsBiometrika1983704155
- CAPRIE Steering CommitteeA randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)Lancet1996348132913398918275
- SharisPJLoscalzoJThienopyridines: ticlopidine and clopidogrelSasaharaALoscalzoJNew Therapeutic Agents in Thrombosis and Thrombolysis2nd edNew York, NYInforma Healthcare2003
- AndresEPerrinAEAltMGoichotBSchliengerJLFebrile pancytopenia associated with clopidogrelArch Intern Med200116112511146710
- SuhSYRhaSWKimJWNeutropenia associated with clopidogrel use in a patient with chronic renal failure who underwent percutaneous coronary and peripheral interventionInt J Cardiol200611238338516271406
- CoxEMartinBCVan StaaTGarbeESiebertUJohnsonMLGood research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force report – part IIValue Health2009121053106119744292